Abolis Biotechnologies in the news
Custom biotech industrial solutions
Tamtam found 20 recent articles about Abolis Biotechnologies.
- French Tech : Abolis, spécialiste de la biologie de synthèse - 17/11
Cyrille Pauthenier of Abolis Biotechnologies discussed their tailored industrial solutions using natural or modified microorganisms on French Tech.
- Abolis et EuroAPI vont mêler biotech et chimie pour produire des corticoïdes à 100 % européens
Abolis Biotechnologies and EuroAPI collaborate to develop fully European-produced corticoids by combining biotech and chemistry, aiming to reduce dependence on Asian suppliers.
- Synbio alliance strengthens EU corticosteroid supply chain
A €140 million EU-backed alliance including Abolis Biotechnologies is developing AI-enhanced synthetic biology processes to produce corticosteroids locally and reduce reliance on Asian imports.
- Euroapi et Abolis Biotechnologies engagent un partenariat stratégique
Abolis Biotechnologies and Euroapi form a strategic partnership to develop microbial strains for corticosteroid production, supported by a major EU health initiative to strengthen European pharmaceutical sovereignty.
- Euroapi et Abolis Biotechnologies engagent un partenariat stratégique...
Abolis Biotechnologies and Euroapi form a strategic partnership to develop microbial strains for corticosteroid production, supported by a major EU health initiative to strengthen European pharmaceutical sovereignty.
- Révolution biotech : Abolis et son président, Cyrille Pauthenier, sur la voie du succès
Abolis Biotechnologies secured 35 million euros to expand its eco-friendly biotech production of sustainable ingredients, partnering with major firms like L'Oréal and Evonik.
- Abolis Biotechnologies Lands €35M to Boost R&D and Address Biotech Market Challenges
Abolis Biotechnologies raised €35M to enhance R&D and scale biomanufacturing, while addressing industry challenges like competitiveness and feedstock limitations.
- Synthetic Biology Events, Info, & Industry Information
Abolis Biotechnologies raised €35 million to expand and develop eco-friendly biomanufacturing solutions amid industry challenges and strategic partnerships.
- L'Oréal's Biotech Venture to Reshape Cosmetics Supply Chain
L'Oréal teams up with Abolis Biotechnologies and Evonik to develop sustainable bio-based ingredients, advancing its eco-friendly cosmetics supply chain goals.
- Abolis Biotechnologies secures €35 M to accelerate sustainable biotech growth
Abolis Biotechnologies secured €35M to expand sustainable biotech solutions globally and partner with L’Oréal and Evonik for market innovation.
- 欧莱雅和赢创与 Abolis 生物技术公司签署合作协议并投资该公司
L'Oréal and Evonik invested in Abolis Biotechnologies to jointly develop sustainable bio-based ingredients for cosmetics and other industries.
- L’Oréal and Evonik acquire minority stakes in Abolis Biotechnologies
L’Oréal and Evonik invested in Abolis Biotechnologies to scale production of sustainable microorganism-derived ingredients for cosmetics and related markets.
- L’Oréal Groupe partners with Abolis and Evonik to scale development of next-generation bio-based ingredients
L’Oréal, Abolis Biotechnologies, and Evonik collaborate and invest to scale sustainable bio-based ingredients for beauty products.
- L’Oréal Partners with Abolis and Evonik for Next-Gen Bio-Based Ingredients
L’Oréal, Abolis Biotechnologies, and Evonik have partnered to accelerate the development and production of sustainable bio-based ingredients for beauty products, supporting L’Oréal’s 2030 sustainability goals.
- French biotech Abolis Biotechnologies raises €35M to boost microbial ecosystem engineering
Abolis Biotechnologies secured €35M funding and strategic partnerships to scale microbial ecosystem engineering and biomanufacturing for sustainable industrial solutions.
- Abolis Biotechnologies booste ses recherches grâce à une levée de fonds de 35 millions d’euros
Abolis Biotechnologies secured 35 million euros to advance its eco-friendly microbial biotechnology innovations across multiple industries.
- Essonne : une start-up implantée au Genopole annonce une impressionnante levée de fonds
Abolis Biotechnologies raised €35 million to expand its eco-friendly biotech production using microorganisms, partnering with L’Oréal and Evonik, and growing internationally.
- L'Oréal entre au capital de la biotech francilienne Abolis
L'Oréal invested in Abolis Biotechnologies, a French biotech producing microorganism-based ingredients for cosmetics and other markets.
- L'Oréal et Evonik signent un partenariat avec Abolis Biotechnologies et investissent dans la société
L'Oréal and Evonik invest in Abolis Biotechnologies to jointly develop sustainable bio-sourced ingredients for the beauty industry.
- Abolis Biotechnologies lève 35 millions d’euros pour accélérer l’analyse du microbiome.
Abolis Biotechnologies secured €35 million to accelerate international expansion and develop innovative biosourced bioprocesses and microbiome analysis solutions.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Abolis Biotechnologies?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies